Biotechnology sector-related ETFs surged Monday after Celgene (NasdaqGS: CELG) said it will acquire Juno Therapeutics (NasdaqGS: JUNO) to expand its cancer treatment profile. Among the best performing biotech-related ETFs, the First Trust NYSE Arca Biotechnology Index Fund (NYSEArca: FBT) jumped...